Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Genetics|April 24, 2023
Schizophrenia and cardiometabolic abnormalities: A Mendelian randomization studyNoushin Saadullah Khani, Marius Cotic, Baihan Wang, et al.
Journal of Psychopharmacology (Oxford, England)|February 11, 2023
Associations of antidepressants and antipsychotics with lipid parameters: Do <i>CYP2C19</i>/<i>CYP2D6</i> genes play a role? A UK population-based studyAlvin Richards-Belle, Isabelle Austin-Zimmerman, Baihan Wang, et al.
Wellcome Open Research|February 11, 2025
Hearing problems in humans and mouse models with rare copy number variants associated with schizophrenia: a scoping review protocolStephen Murtough, Daniele Panconesi, Chen Lu, et al.
Psychological Medicine|November 24, 2023
Is auditory processing measured by the N100 an endophenotype for psychosis? A family study and a meta-analysisBaihan Wang, Leun J Otten, Katja Schulze, et al.
Frontiers in Pharmacology|October 27, 2025
Patient and clinician perspectives on pharmacogenetic testing for antipsychoticsMaria Richards-Brown, Yiran Wei, Rosemary Abidoph, et al.
Nature. Mental Health|May 15, 2024
A systematic review of pharmacogenetic testing to guide antipsychotic treatmentNoushin Saadullah Khani, Georgie Hudson, Georgina Mills, et al.
Translational Psychiatry|November 21, 2025
Effect of polygenic scores on the relationship between psychosis and cognitionLauren Varney, Krisztina Jedlovszky, Baihan Wang, et al.
The Pharmacogenomics Journal|January 20, 2026
Pharmacogenomics to optimise psychotropic prescribing: a survey of mental health professionals' perceptions, knowledge, and educational needsDaniele Panconesi, Stephen Murtough, Marius Cotic, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Effect of <i>CYP1A2</i>, <i>CYP2D6</i>, and <i>CYP3A4</i> Variation on Antipsychotic Treatment OutcomesLauren Varney, Stephen Murtough, Marius Cotic, et al.
Pageof 1